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student), anticonvulsants (2.8 Rx/student), adrenergics/amphet-
amine (2.4 Rx/student), antidepressants (2.3 Rx), and antipsy-
chotics (1.9 Rx/student). After controlling for demographics and
Medicaid enrollment status, ANCOVA indicated a signiﬁcant
SBHC intervention effect (Time*SBHC) for both monthly total
cost (F = 8.82, p = 0.003) and monthly mental health service cost
(F = 5.06, p = 0.025). CONCLUSION: The SBHC program that
provides mental health services for students did not decrease the
total Medicaid costs, instead, might increase the health quality
and health care accessibility for students with mental illnesses,
and this hypothesis should be examined in future research.
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OBJECTIVE: Case studies of behavioral carve-outs using
pre/post designs have found that they results in substantial
savings. Prior studies have not, however, examined the impact of
behavioral carve-outs on psychotropic medication usage and
costs. This study ﬁlls this gap. METHODS: Data came from
Medstat’s MarketScan claims database. The sample comprised
ten large employers with and without behavioral carve-outs. The
employers included about 1.4 million employees and their depen-
dents (about 890,000 were enrolled in carve-outs and 521,000
in non-carve-outs). A 2-part model was used to examine differ-
ences in the probably of use and the cost of services among users.
Total costs, inpatient, outpatient, and pharmaceutical costs were
examined. Independent variables included age, gender, diagno-
sis, region, plan type, and plan ﬁxed effects (to control for beneﬁt
design). Predicted expenditures were calculated using the smear-
ing technique. Inpatient and outpatient behavioral health claims
were identiﬁed by diagnosis. Psychotropic medications were
identiﬁed by the Redbook classiﬁcation system. RESULTS: There
was no difference in the probability of using pharmaceuticals or
the costs of pharmaceuticals among users between carve-outs
and non-carve-outs; although, predicted pharmaceutical expen-
ditures were lower for carve-outs ($4.80 versus $3.90). Carve-
outs had a lower probability of using inpatient care and
outpatient care. Carve-outs had higher costs for outpatient care
among users. The other differences were not statistically signiﬁ-
cant. Total predicted costs for carve-outs were about 28% lower
than for non-carve-outs. CONCLUSIONS: Behavioral carve-
outs have an incentive to shift usage away from mental health
ambulatory and hospital services and towards pharmaceuticals
because pharmaceutical usage is typically off the budget for
which they are held accountable. However, without very aggres-
sive utilization review, behavioral carve-outs may not have the
tools to inﬂuence pharmaceutical usage. This study ﬁnds that the
main effect of behavioral carve-outs is on the probably of inpa-
tient and outpatient behavioral health service usage.
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OBJECTIVES: The association between mental distress and
health risks, protective health behavior (in the form of preven-
tive health screenings) and health care costs was evaluated
among a commercially insured, adult population. METHODS:
The sample contains 10,055 employees age 18–75, which is a
sub-set of the managed care, health risk assessment database
[MCHRA]. The MCHRA data was collected from 2000–2003.
Bi-variable analysis, logistic regression and general linear regres-
sion models were performed to evaluate the association between
mental distress (low, medium and high) and health risks, health
lifestyle, preventive health screenings, and health care costs.
RESULTS: Using multi-variable logistic regression models, those
with high mental distress were signiﬁcantly more likely to smoke
(adjusted odds ratio [AOR] 1.26, p = 0.0027), drink alcohol
(AOR 5.75, p < 0.0001), more likely to not wear a helmet when
biking (AOR, 1.37, p = 0.0188), more likely to be overweight
(AOR 1.21, p = 0.0350), more likely to feel a loss of self esteem
(AOR 8.86, p < 0.0001), more likely to have lost interest in life
(AOR 12.23, p < 0.0001), more likely to report depression (AOR
16.53, p < 0.0001), more likely to have sleep problems (AOR,
3.81, p < .0001) and less likely to be tested for colon cancer
through FOBT tests (AOR 1.429, p = .0006) or colonoscopy
(AOR 1.93, p < 0.0001). Those with mental distress were more
likely to have higher health care costs overall (>$1,700; F =
20.08, p < 0.0001). Health care cost areas associated with
disease classiﬁcations showed those with higher distress had
higher costs related to treatment of mental disorders (>$140; F
= 44.50, p < 0 .0001), the nervous system (>$70; F = 3.34, p =
0.0675) and respiratory system (>$120; F = 15.36, p < 0.0001).
CONCLUSIONS: The ﬁndings indicate a strong association
between mental distress, health risk and lifestyle, and preventive
health behavior and health care costs.
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OBJECTIVES: Unlike many other health care organizations,
central Texas veterans do not have day supply limits on med-
ications. Thus, the potential for medication over-adherence
exists. The objectives of this study were to: 1) examine the adher-
ence rate (AR) and medication possession ratio (MPR) among
veterans taking antipsychotics; 2) determine whether over-
adherence (AR > 1 or MPR > 1) exists among veterans taking
antipsychotics; and 3) evaluate factors related to over-adherence.
METHODS: Data were extracted from the Central Texas Vet-
erans Health Care System (CTVHCS) from September 1995—
October 2002 for continuously enrolled adult outpatients who
were on monotherapy, and had at least two prescriptions within
a year. Demographic and relevant clinical information, including
age, gender, ethnicity, psychiatric diagnoses, and antipsychotic
prescription medication information were collected. Subjects
were followed up to 12 months. RESULTS: Among the eligible
patients (N = 3252), the mean AR was 1.56 (sd = 2.58) and MPR
was 1.23 (sd = 0.75). Over one-half (54.4%) of the subjects were
over-adherent with ARs and MPRs > 1. For those over-adherent
patients, the mean AR was 2.38 (sd = 3.27) and MPR was 1.70
(sd = 0.71). Multiple logistic analyses revealed that schizophrenic
patients (OR = 1.241, p = 0.0085) were signiﬁcantly more likely
to be over-adherent (MPR > 1), while nonwhite (OR = 0.617, p
< 0.0001), depressed patients (OR = 0.801, p = 0.0085) and
atypical users (OR = 0.620, p < 0.0001) were signiﬁcantly less
likely to be over-adherent. A second logistic analysis to assess
individual antipsychotic agents showed that, compared to
haloperidol, quetiapine users (OR = 2.309, p = 0.0073) were sig-
niﬁcantly more likely to be over-adherent, and olanzapine (OR
